PDCD1 and hereditary sensory and autonomic neuropathy: Studies have shown that prior lung disease, tumor type, use of PD-1 inhibitors, combination therapy, chest radiotherapy, smoking history, and age >70 years are risk factors for CIP (31, 32), The main risk factors for our patient were lung squamous cell carcinoma, a smoking history, and the use of PD-1 inhibitors.